3 – 5 December 2020 Sydney Australia

The VERVE Symposium in conjunction with LINC Australia program will incorporate a world renowned international faculty, with live cases from the University Hospital in Leipzig, Prince of Wales Private Hospital Sydney and the Mater Hospital Sydney. We are introducing a call for abstracts in the categories of original scientific research and challenging cases with a chance for individuals to join the faculty for a podium or e-poster presentation, providing endovascular techniques, peripheral, carotid, aortic and late breaking trial data and the opportunity for individuals to present their research.

ENDOVASCULAR MASTERCLASS AND GLOBAL EXPERT DISCUSSION FORUM

*Program subject to change
To view the session content, please click on the arrow to the right of the session.

Thursday 5 December 2019    Venue: Parkside Ballroom – Level 2
07:00 am
Registration Desk Open

7:00 - 7:00 am

Venue – Parkside Ballroom Level 2

VERVE Symposium: Room 1
08:30 - 10:00 am
Session 1.1: The Paclitaxel Controversy: What We’ve Learned About Paclitaxel Over the Last 12-Months

8:30 - 10:00 am

Chairs : R. Varcoe, P. Schneider
Panel : M. Brodmann, G. Ansel, J. Van den Berg, I. Meredith

8:30 - 8:35 am

Introductory Remarks
Ramon Varcoe

8:35 - 8:50 am

Live Case from Leipzig (case 1)

8:50 - 8:58 am

Drug Eluting Technology: What Was the Impact of the JAHA Meta-Analysis 1-Year Later
Marianne Brodmann

8:58 - 9:06 am

Paclitaxel Insights from the TOTAL IN.PACT Program
Peter Schneider

9:06 - 9:14 am

Is Drug Based Technology Appropriate for Claudicants, CLI and Dialysis Access?
Gary Ansel

9:14 - 9:22 am

Insights from Coronary Paclitaxel DES Era – Setting the Record Straight 20 Years On
Ian Meredith

9:22 - 9:32 am

Live Case from Leipzig (case 1)

9:32 - 9:40 am

Alternative Explanations for the Safety Signal: The Impact of Clinical Trial Design
Ramon Varcoe

9:40 - 10:00 am

Discussion

10:00 - 10:30 am
Morning Tea
10:30 - 12:00 pm
Session 1.2: Future Directions in SFA Treatment

10:30 - 12:00 pm

Chair : R. Varcoe
Panel : M. Brodmann, D. Holdaway, K. Rosenfield, A. Ling, I. Spark

Supported by : Abbott Vascular

10:30 - 10:38 am

What is the Role of Open Vascular Surgery in PAD disease in 2020: An Overview of Proposed Indications
Marianne Brodmann

10:38 - 10:46 am

Supera Interwoven Nitinol stent for the Treatment of Femoral and Popliteal arterial Disease
Damien Holdaway

10:46 - 11:14 am

Live Case from POW Sydney (case 3)

11:14 - 11:22 am

Is DCB angioplasty enough in long CTOs?
Ian Spark

11:22 - 11:30 am

Experiences with the Supera Interwoven Nitinol Stent for the Treatment of Severely Calcified Lesions and the Popliteal Artery
Adrian Ling

11:30 - 11:38 am

An Update of the BEST-CLI Trial of Endo vs Open Surgery for Symptomatic PAD
Kenneth Rosenfield

11:38 - 12:00 pm

Discussion

12:00 - 01:00 pm
Lunch
12:00 - 01:00 pm
Lunch Session

12:00 - 1:00 pm

Room 2

Title : ESKD Symposium: Advances of Endovascular Therapy in AV Access

Discussions around new data, guidelines and interventional technology into treatment paradigms for end-stage kidney disease patients

Supported by : BD Bard

Facilitator : Albert Goh

New KDOQI guidelines

Albert Goh

Latest Data on the Covera™ AVeNEW Trial

Philip Puckridge

Use of Lutonix™ 035 Drug Coated Balloon for challenging AV Access Stenosis

Sven Brunlich

01:00 - 02:40 pm
Session 1.3: Pioneering Techniques in Aortoiliac Occlusive Disease

1:00 - 2:40 pm

Chair : S. Bräunlich
Panel : J. Van den Berg, Y. Gouëffic, D. Schneider, P. Mwipitayi

Supported by : Gore

1:00 - 1:20 pm

Live Case from Sydney NSPH (case 4)

1:20 - 1:28 pm

New Technical Developments in Stenting of the Abdominal Aorta and Common Iliac Arteries for Steno-Occlusive Disease
Jos Van den Berg

1:28 - 1:36 pm

A Prospective Registry for the Treatment of Iliac Oclusions with Bare Metal Stent: 2-Year Outcomes
Yann Gouëffic

1:36 - 1:56 pm

Live Case from Auckland (case 5)

1:56 - 2:04 pm

Endografts for Complex Aortoiliac Occlusions
Darren Schneider

2:04 - 2:12 pm

Aortoiliac Occlusive Disease: What Factors Impact Long-Term Outcome after Endovascular Intervention?
Patrice Mwipitayi

2:12 - 2:20 pm

An Update of the VBX Program in Aortoiliac Occlusive Disease
Andrew Holden (via satellite)

2:20 - 2:40 pm

Discussion

02:40 - 04:00 pm
Session 1.4: Beyond Simple Drug Elution: A Combination of Endovascular Tools to Optimise Outcomes

2:40 - 4:00 pm

Chair : B. DeRubertis
Panel : J. Golledge, A. Bullen, D. Robinson, P. Puckridge

Supported by : Medtronic

2:40 - 2:48 pm

Directional Atherectomy for the SFA and Popliteal Arteries
Domenic Robinson

2:48 - 3:08 pm

Live Case from Sydney NSPH (case 6)

3:08 - 3:16 pm

Atherectomy: How to Choose the Best Option, Avoid Problems and Bail Yourself Out
Andrew Bullen

3:16 - 3:24 pm

The Role of Non-Drug Eluting Technologies for Fem-Pop Revascularization in Light of the Paclitaxal Data
Phil Puckridge

3:24 - 3:30 pm

Live Case from Sydney NSPH (case 6 continued)

3:30 - 3:38 pm

The Evidence for Hyperbaric Oxygen Therapy in Patients with Diabetes-Related Foot Ulcers
Jonathan Golledge

3:38 - 3:46 pm

Versatility in Vessel Preparation – Directional Atherectomy
Brian DeRubertis

3:46 - 3:54 pm

An Australian Experience Using Combination Therapy Below the Knee
Vik Puttaswamy (via satellite)

3:54 - 4:00 pm

Discussion

04:00 - 04:15 pm
Afternoon Tea
04:15 - 06:00 pm
Session 1.5: The Last Frontier of the Aortic Arch

4:15 - 6:00 pm

Chairs : H. Verhagen, E. Verhoeven
Panel : T. Kolbel, F. Criado, R. Tripathi, E. Ducasse

Supported by : Gore

4:15 - 4:23 pm

The New C-Tag with Active Controlled Deployment is a Game Changer for TEVAR and Well Suited to the Aortic Arch
Hence Verhagen

4:23 - 4:31 pm

Recorded Case: Aortic Arch and Descending TEVAR
Hence Verhagen

4:31 - 4:51 pm

Live Case from Auckland (case 8)

4:51 - 4:59 pm

Treating Concomitant Disease of the Arch and Thoracic Aorta
Eric Verhoeven

4:59 - 5:07 pm

Key Strategies to Prevent Retrograde Type A Dissection During TEVAR
Frank Criado

5:07 - 5:15 pm

Live Case from Auckland (case 8)

5:15 - 5:23 pm

Endovascular Repair of the Ascending and Aortic Arch
Tilo Kolbel

5:23 - 5:31 pm

Coronary Artery Bypass Grafting (CABG) combined with concomitant endovascular Hybrid repair of Aortic Arch Aneurysms.
Ramesh Tripathi

5:31 - 5:39 pm

CTAG with Active Control: Conformable, Controlled, Predictable 
Eric Ducasse

5:39 - 6:00 pm

Discussion

06:00 pm
Close of Day 1
06:00 - 07:30 pm
Welcome Reception

6:00 - 7:30 pm

Venue: Parkside Ballroom Level 2

VERVE Symposium: Room 2
08:30 - 10:00 am
Session 2.1: Updates in Abdominal Aortic Aneurysm Treatment

8:30 - 10:00 am

Chairs : H. Verhagen, F. Criado
Panel : M. Schermerhorn, P. Holt, R. Milner, E. Verhoeven, E. Ducasse

8:30 - 8:35 am

Introductory Remarks
Hence Verhangen

8:35 - 8:43 am

These are the Current Unmet Needs in AAA Treatment
Frank Criado

8:43 - 9:03 am

Live Case from Sydney NSPH (case 2)

9:03 - 9:11 am

EVAR is Associated with Increased Risk in Patients with Increased Luminal Space (Not Sac Diameter)
Hence Verhagen

9:11 - 9:19 am

Treatment Options for Type II Endoleak
Marc Schermerhorn

9:19 - 9:27 am

Outcomes after Endovascular Aneurysm Sealing (EVAS) in 298 Patients
Peter Holt

9:27 - 9:35 am

Live Case from Sydney NSPH (case 2)

9:35 - 9:43 am

Right axillary access is effective and safe for Complex EVAR, ChEVAR and FEVAR
Ross Milner

9:43 - 9:51 am

CO² Imaging Use in PAD and EVAR Treatment. It Really Works!
Eric Ducasse

9:51 - 10:00 am

Discussion

10:00 - 10:30 am
Morning Tea
10:30 - 12:00 pm
Session 2.2: Ultrasound Session I: The Value of Ultrasound in Complementing Procedural Vascular Care

10:30 - 12:00 pm

Chair : K Weaver

10:30 - 10:40 am

Doppler Angle Correction in Vascular Sonography
Teal Derboghossian

10:40 - 10:50 am

Cystic Adventitial Disease
Nathan Gallagher

10:50 - 11:00 am

Duplex Findings in Unusual Venous Pathology
Ian Catchpole

11:00 - 11:10 am

New Ultrasound Technologies: V-Flow
Tricia Mares

11:10 - 11:20 am

IVUS Guided Viabahn Stentgraft Implantation for the Most Complex Femoropopliteal Lesions
Osamu Iida

11:20 - 11:30 am

Takayasu’s in a Young Female Patient: Case study
Daniel Cai

11:30 - 11:40 am

Mega Fistula – Complication of Dialysis Fistulas
Adam Tolfree

11:40 - 11:50 am

Asymptomatic Carotid Artery Screening: Con or Common Sense?
Matt Adams

11:50 - 12:00 pm

Scanning Protocol of an Athlete with Claudication: Case Study of Endofibrosis
Jiawei (Andy) Yang

12:00 - 01:00 pm
Lunch
12:00 - 01:00 pm
Lunch Session

12:00 - 1:00 pm

Title : ESKD Symposium: Advances of Endovascular Therapy in AV Access

Discussions around new data, guidelines and interventional technology into treatment paradigms for end-stage kidney disease patients

Supported by : BD Bard

Facilitator : Albert Goh

New KDOQI guidelines

Albert Goh

Latest Data on the Covera™ AVeNEW Trial

Philip Puckridge

Use of Lutonix™ 035 Drug Coated Balloon for challenging AV Access Stenosis

Sven Brunlich

01:00 - 02:40 pm
Session 2.3: Issues and Controversy in Major Vein Disorders

1:00 - 2:40 pm

Chairs : L. Villalba, P. Mwipitayi
Panel : R. Tripathi, M. Razavi, T. Nguyen, L. Leon

Supported by : Philips

1:00 - 1:10 pm

The Use of IVUS in the Diagnosis and Treatment of Major Vein Disorders: An Indispensable tool
Patrice Mwipitayi

1:10 - 1:20 pm

Endovascular Management of Inferior Vena Cava: Acute and Chronic Obstruction
Luis Leon

1:20 - 1:30 pm

Failure modes of Iliac veins stents and what we can do about them
Ramesh Tripathi

1:30 - 1:40 pm

Deep Venous In-Stent Restenosis: Pathological Evidence as to its Cellular Origins
Cameron Robertson

1:40 - 1:50 pm

Treatment of Venous Thoracic Outlet Syndrome Using Angiojet, Rib Resection and Vein Patch Reconstruction
Tam Nguyen

1:50 - 2:00 pm

Strategies for Managing Central Venous Occlusions
Mahmood Razavi

2:00 - 2:10 pm

Crossover catheter-directed thrombolysis for Acute DVT involving the whole leg
Mingjin Guo

2:10 - 2:20 pm

Latest Results from the INFINITE-OUS BlueLeaf Endovenous Valve Formation System
Thodur Vasudevan

2:20 - 2:30 pm

Real Patient Stories of Surviving DVT and PE
Laurencia Villalba

2:30 - 2:40 pm

Discussion

02:40 - 04:03 pm
Session 2.4: EVAR and Challenging Anatomy

2:40 - 4:00 pm

Chair : R. Milner
Panel : E. Verhoeven, M. Sebastian, E. Ducasse, D. Schneider

2:40 - 2:48 pm

Experience with the Gore Excluder graft in More than 300 cases: Does Off IFU Matter?
Eric Verhoeven

2:48 - 3:08 pm

Live Case from POW Sydney (case 7)

3:08 - 3:16 pm

How the Endurant Graft Improves My Ability to Treat More Challenging Aortic Necks with Good Long-Term Outcomes
Ross Milner

3:16 - 3:24 pm

The Use of EVAR for the Treatment of Mycotic Aneurysms
Mathew Sebastian

3:24 - 3:32 pm

Tips and Tricks for a Perfect Physician Modified Fenestrated Endograft when Required
Eric Ducasse

3:32 - 3:47 pm

Live Case from POW Sydney (case 7)

3:47 - 3:55 pm

FEVAR and BEVAR for the Management of Failed EVAR
Darren Schneider

3:55 - 4:03 pm

EVAR in Complex Anatomy, Lessons Learned from ENGAGE and GREAT Registries
Patrice Mwipitayi

Discussion

04:00 - 04:15 pm
Afternoon Tea
04:15 - 06:00 pm
Session 2.5: The Challenges of Limb Salvage in Advanced BTK Disease

4:15 - 6:00 pm

Chairs : P. Schneider, S. Braunlich
Panel : J. Mustapha, T. Nakama, J. Golledge, M. Brodmann

4:15 - 4:23 pm

Rutherford 6 wounds-the utility of multi-vessel revascularization and inflow strategies
Peter Schneider

4:23 - 4:31 pm

The Technique of Distal Puncture for BTK Occlusion
Tatsuya Nakama

4:31 - 4:51 pm

Live Case from Leipzig (case 9)

4:51 - 4:59 pm

Using Rotarex in BTK Arteries: Where Can it be Used Most Safely and Effectively
Sven Bräunlich

4:59 - 5:07 pm

Does the Downstream Effect After Drug-Coated Balloon Treatment Impact Time to Wound Healing in CLI?
Osamu Iida

5:07 - 5:22 pm

Live Case from Leipzig (case 10)

5:22 - 5:30 pm

How Best to Define and Treat “No Option” CLI Patients
Marianne Brodmann

5:30 - 5:38 pm

Venous Arterialization for Patients with Recurrent TLR Facing Possible Amputation: Results from a Single Center Observational Study
Jihad Mustapha

5:38 - 5:46 pm

The Unrealized Potential of Effective Medical Management in People with Peripheral Artery Disease
Jonathan Golledge

5:46 - 6:00 pm

Discussion

06:00 pm
Close of Day 1
06:00 - 07:30 pm
Welcome Reception

6:00 - 7:30 pm

Venue: Parkside Ballroom Level 2

Friday 6 December 2019    Venue: Parkside Ballroom – Level 2
07:00 am
Registration Desk Open

7:00 - 7:00 am

Venue – Parkside Ballroom Level 2

VERVE Symposium: Room 1
08:00 - 09:30 am
Session 1.6: Latest Clinical Trial Releases and Advances in PAD Treatment

8:00 - 9:30 am

Chair: G. Ansel
Panel : Y. Goueffic, L. Villalba, N. Altaf

Supported by : Boston Scientific

8:00 - 8:08 am

SAVAL BTK Trial Update: Unique Stent Technology for Complex Tibial Anatomy
Sven Braunlich

8:08 - 8:28 am

Live Case from Leipzig (Case 11)

8:28 - 8:36 am

An Australian Health Economic Evaluation for the Eluvia drug-eluting stent
Nishath Altaf

8:36 - 8:44 am

Final Results of the Ranger II Pivotal Trial
Marianne Brodman

8:44 - 9:02 am

Live Case from Leipzig (case 11)

9:02 - 9:10 am

Jetstream Atherectomy for the Treatment of In-stent Restenosis of the Femoropopliteal Artery: Preliminary Results of the JET-ISR Study
Patrice Mwipitayi

9:10 - 9:18 am

ELUVI – An Update
Andrew Holden

9:18 - 9:30 am

Discussion

09:30 - 11:00 am
Session 1.7: Complex PAD Lesions and New Clinical Trial Data

9:30 - 11:00 am

Chair : Sven Braunlich
Panel : S. Bräunlich, J. Van den Berg, S. Thomas, L. Leon

Supported by : BD Bard

9:30 - 9:38 am

An Update on the Lutonix PAD Global Registry
Sven Bräunlich

9:38 - 10:00 am

Live Case from MAT Sydney (Case 13)

10:00 - 10:08 am

Safety and Efficacy of the Phoenix Atherectomy System in the Treatment of Multilevel Infrainguinal Arterial Disease
Luis Leon

10:08 - 10:16 am

Innovative Solutions to Complex Re-Do CLI Procedures
Shannon Thomas

10:16 - 10:24 am

The Lutonix BTK Trial 1-Year Update: Which Direction Should These Results Take Us?
Sven Braunlich

10:24 - 10:34 am

Live Case from MAT Sydney (case 13)

10:34 - 10:42 am

The Treatment of Embolic Complications in Peripheral Vascular Interventions
Jos Van den Berg

10:42 - 11:00 am

Discussion

11:00 - 11:30 am
Morning Tea
11:30 - 01:00 pm
Session 1.8: Thoracic Aortic Aneurysms and Dissection

11:30 - 1:00 pm

Chairs : R. Milner, F. Criado
Panel : M. Schermerhorn, R. Qasabian, T. Kolbel, E. Verhoeven

Supported by : Medtronic

11:30 - 11:38 am

Update from the Valiant Navion clinical trial: A New Generation of TEVAR device
Ross Milner

11:38 - 11:53 am

Recorded Case from Auckland (case 14)

11:53 - 12:01 pm

Chronic Dissection and False Lumen Occlusion Techniques
Tilo Kolbel

12:01 - 12:09 pm

Setting up a Thoracoabdominal Program in an Australian Teaching Hospital
Raffi Qasabian

12:09 - 12:16 pm

3D Printing and Customized Pre-fenestration and Branched Stent Graft for the Treatment for Thoracoabdominal Aortic Diseases
Liu Zhao

12:16 - 12:24 pm

What is the Stroke Risk from Complex EVAR and TEVAR: Real World Data from the VQI
Marc Schermerhorn

12:24 - 12:32 pm

An Update of the Treatment of Chronic Dissections
Eric Verhoeven

12:32 - 12:39 pm

Treated covered stent:a reasonable choice for TEVAR of acute aortic dissection
Jian Zhang

12:39 - 12:47 pm

How to Manage the “Fragile” Thoracic Aorta
Phil Puckridge

12:47 - 12:55 pm

Update on Thoracic IMH: Further insights on its nature and indications for intervention
Frank Criado.

12:55 - 1:00 pm

Discussion

01:00 - 02:00 pm
Lunch
01:00 - 02:00 pm
Lunch Session

1:00 - 2:00 pm

Room 2

Title : New horizons in endovascular care for challenging aortic anatomies. Today and tomorrow.

Supported by : Gore

Facilitator : Hence Verhagen

New approaches to the treatment of challenging aortic anatomies

Hence Verhagen

New horizons in endovascular care: An innovative thoracoabdominal branched device

Darren Schneider

Advanced thoracic innovations for improved physician experience and clinical outcomes

Eric Ducasse

02:00 - 03:30 pm
Session 1.9: Advanced Concepts in Deep Venous Disease

2:00 - 3:30 pm

Chairs : R. De Graaf, M. Razavi
Panel : R. Tripathi, P. Puckridge, P. Mwipitayi

Supported by : BD Bard

2:00 - 2:20 pm

The Technique of Venous Stenting: What We’ve Learned About the Most Challenging Aspects of this Emerging Field
Rick De Graaf

2:20 - 2:28 pm

Have Venous Stent Trials Revealed Any New Data?
Mahmood Razavi

2:28 - 2:53 pm

Live Case from MAT Sydney (Case 15)

2:53 - 3:01 pm

Results from an Australian Venous Stenting Program
Phil Puckridge

3:01 - 3:09 pm

Endophlebectomy And Iliac Vein Stent Placement – How I Do It (Video Technique Demonstration) 
Ramesh Tripathi

3:09 - 3:17 pm

Latest Update from the VERNACULAR Trial
Steven Dubenec (via satellite)

3:17 - 3:30 pm

Discussion

03:30 - 04:00 pm
Afternoon Tea
04:00 - 06:00 pm
Session 1.10: Controversies in Aortic Aneurysm Management, Druability of EVAR and the Effect of Volume

4:00 - 6:00 pm

Chair : H. Verhagen
Panel : P. Holt, M. Schermerhorn, E. Verhoeven, I. Mohan

4:00 - 4:15 pm

What’s the Role of Open AAA Surgery in 2020 and Beyond?
Hence Verhagen

4:15 - 4:30 pm

Does Operator and Hospital Volume Make a Difference to Outcomes after Elective and Emergency Aortic Surgery? Results from the Australasian Vascular Audit
Ramon Varcoe

4:30 - 4:40 pm

Complete Replacement of Open Repair for Ruptured Abdominal Aortic Aneurysms by Emergent Endovascular Repair: A 7-Year Experience from A Vascular Centre in Mainland China
Jianing Yue

4:40 - 4:50 pm

An International Comparison of AAA Treatment Rates Across Nine Countries
Peter Holt

4:50 - 5:00 pm

EVAR vs Open Surgical Repair: How Do we Choose the Right Option for Any Given Patient
Marc Schermerhorn

5:00 - 5:10 pm

Centralisation versus Proctoring for Fenestrated and Branched Aortic Stent Grafting: Which Provides Better Outcomes?
Eric Verhoeven

5:10 - 5:20 pm

Endovascular management of ruptured thoracic aortic aneurysm: An Australasian experience
Ian Barry

5:20 - 5:30 pm

DEBATE: Centralization of Elective AAA Results in Safer Surgery with Lower Perioperative Risk
FOR the motion: Peter Holt

5:30 - 5:40 pm

DEBATE: Centralization of Elective AAA Results in Safer Surgery with Lower Perioperative Risk
AGAINST the motion: Irwin Mohan

5:40 - 6:00 pm

Discussion

06:00 pm
Close of Day 2
07:00 - 11:00 pm
Symposium Dinner

7:00 - 11:00 pm

Venue: Sergeants Mess, Chowder Bay

6.45 pm – Transfers: Convention Centre Wharf outside Sofitel Sydney Hotel
Coach transfers back to Sofitel Sydney

VERVE Symposium: Room 2
08:00 - 09:30 am
Session 2.6: Advanced Concepts in AAA Treatment

8:00 - 9:30 am

Chairs : R. Milner, R. Varcoe
Panel : V. Bhamidi, E. Ducasse, E. Verhoeven, D. Schneider

8:00 - 8:08 am

Computational Analysis of Seal Zone Preservation and Migration Resistance with EndoAnchors
Ross Milner

8:08 - 8:28 am

Live Case from Sydney POW (case 12)

8:28 - 8:35 am

Heli-FX: Mid-term results from the ANCHOR Registry: How EndoAnchors Expand EVAR Patient Applicability
Venu Bhamidi

8:35 - 8:43 am

Complications Whilst Waiting for F/BEVAR Stent-Grafts: The Results Might Surprise You
Eric Verhoeven

8:43 - 8:51 am

The IBE: With a Dedicated IIA Component Which Shows Excellent Patency Data
Eric Ducasse

8:51 - 8:59 am

Techniques to Extend the Applicability of lliac Branch Devices
Darren Schneider

8:59 - 9:07 am

Complications and Management Following EVAR during Midterm Follow-up: a Single Center Experience
Jichun Zhao

9:07 - 9:15 am

Dealing with the pending vascular surgery shortage in a multi-institutional vascular institute
Gary Ansel

9:15 - 9:30 am

Discussion

09:30 - 11:00 am
Session 2.7: Ultrasound Session 2: A New Horizon for Vascular Ultrasound

9:30 - 11:00 am

Chairs : J. Robinson, K Weaver

9:30 - 9:40 am

Recommendations & Reality of Infection Protection in the vascular imaging department
John Shirley

9:40 - 9:50 am

Experience with Ultrasound Guided Tibial Angioplasty
Sven Brunlich

9:50 - 10:00 am

No Source Identified?! Venous Malformation in the Form of an intraosseous Perforator
Peter Sharman

10:00 - 10:10 am

llio-Femoral Obstructions: Can We Improve Detection Rates?
Dan Rae

10:10 - 10:20 am

Duplex Findings in Unusual Venous Pathology
Ian Catchpole

10:20 - 10:30 am

What the! – Unusual Arterial Pathologies
Warren Lewis

10:30 - 10:40 am

Pedal Acceleration Time (PAT): A Novel Technique to Evaluate Perfusion in the foot
Jill Sommmerset/Desarom Teso

10:40 - 10:50 am

Live scan: Technique and Application of PAT
Jill Sommmerset/Desarom Teso

10:50 - 11:00 am

How to Set‐up and Perform Contrast‐Enhanced Ultrasound
Gerry Hill

11:00 - 11:30 am
Morning Tea
11:30 - 01:00 pm
Session 2.8: The Paclitaxel Controversy Continues

11:30 - 1:00 pm

Chairs : G. Ansel, P. Schneider
Panel : M. Brodmann, A. Holden, K. Rosenfield, O. Iida

11:30 - 11:45 am

A Summary of the VIVA Vascular Leaders Forum
Gary Ansel

11:45 - 11:53 am

Paclitaxel-Is it safe and how should we use it in PAD patients?
Peter Schneider

11:53 - 12:01 pm

Long-Term Results from the IN.PACT Japan Trial
Osamu Iida

12:01 - 12:09 pm

Safety Results from the Lutinox Paclitaxel Coated Balloon Studies
Marianne Brodmann

12:09 - 12:17 pm

ELUVIA – An Update
Andrew Holden

12:17 - 12:25 pm

Long Term Safety and Efficacy of IN.PACT Admiral:  (IN.PACT 5 year data)
Brian DeRubertis

12:25 - 12:33 pm

Outcome From a DCB Series versus Historical Control: Recurrence and  Mortality
Kishore Sieunarine

12:33 - 12:41 pm

The Impact of Dose on the Paclitaxel Issue
Andrew Holden

12:41 - 12:49 pm

A Coalition of Seven Vascular Societies: Joint Position Statement on Paclitaxel Coated Devices
Kenneth Rosenfield

12:49 - 12:57 pm

Are There Alternatives to Paclitaxel? Different Immunosuppressive Drugs to Prevent Restenosis
Marianne Brodmann

12:57 - 1:00 pm

Discussion

01:00 - 02:00 pm
Lunch
01:00 - 02:00 pm
Lunch Session

1:00 - 2:00 pm

Title : New horizons in endovascular care for challenging aortic anatomies. Today and tomorrow.

Supported by : Gore

Facilitator : Hence Verhagen

New approaches to the treatment of challenging aortic anatomies

Hence Verhagen

New horizons in endovascular care: An innovative thoracoabdominal branched device  

Darren Schneider

Advanced thoracic innovations for improved physician experience and clinical outcomes

Eric Ducasse

02:00 - 03:30 pm
Session 2.9: New Horizons in Dialysis Access Intervention

2:00 - 3:30 pm

Chair : J. Swinnen
Panel : I. Nammuni, A. Holden, M. Razavi

2:00 - 2:08 pm

Optimising Dialysis Outcomes in the Next Decade: Challenges & Potential Solutions
John Swinnen

2:08 - 2:28 pm

Latest Data From the LUTONIX DCB in AVF Trial
Gerard Goh

2:28 - 2:46 pm

Live Case from Sydney POW (case 16)

2:46 - 2:54 pm

Update of the In.Pact AV Access RCT – Primary Endpoint and Sub-group Analysis
Andrew Holden

2:54 - 3:00 pm

A Superior Approach to Dialysis Fistulography? The Benefits of Using Internal Jugular Access to Perform Diagnostic Angiograms and Interventions
Wasim Hakim

3:00 - 3:08 pm

Mortality After DCB Use in the Failing AVF: A Meta-Analysis of RCTs
Krystal Dinh

3:08 - 3:14 pm

Mortality and Patency of Fistulas treated with Drug-Coated Balloons  A Single Centre Retrospective Review
Christina Popovic

3:14 - 3:20 pm

The novel endovascular plication of a thigh arteriovenous fistula using an EVAR limb to treat high-output cardiac failure
Thomas Cavaye

3:20 - 3:28 pm

Forced Maturation of the Arteriovenous Fistula Using Nitinol Stents
Shannon Thomas (via satellite)

3:28 - 3:30 pm

Discussion

03:30 - 04:00 pm
Afternoon Tea
04:00 - 06:00 pm
Session 2.10: New Technology with the Potential to Improve Outcomes in PAD Treatment

4:00 - 6:00 pm

Chairs : A. Holden, G. Ansel
Panel : P. Schneider, T. Nakama, M. Razavi, M. Brodmann

4:00 - 4:08 pm

New Devices and Innovations for Managing CLI
Peter Schneider

4:08 - 4:33 pm

Live Case from Leipzig (case 17)

4:33 - 4:41 pm

Summarising the TOBA Evidence from the Above and Below Knee Clinical Trial Data
Marianne Brodmann

4:41 - 4:49 pm

Intravascular lithoplasty: Study Status (DISRUPT PAD II and III) and Lessons Learnt from a Real-World Registry
Andrew Holden

4:49 - 4:57 pm

The Various Approaches to Femoro-Popliteal CTOs: From $ to $$$
Gary Ansel

4:57 - 5:20 pm

Live Case from Leipzig (case 18)

5:20 - 5:28 pm

What Does it Mean “No option CLI”? : The Possibility of Percutaneous Deep Venous Arterialization
Tatsuya Nakama

5:28 - 5:36 pm

The Role of a New Generation of Stem Cell Trials in Patients with CLI
Marianne Brodmann

5:36 - 5:44 pm

Optimal Trial Design for Novel Therapies in CLI Patients
Mahmood Razavi

5:44 - 6:00 pm

Discussion

06:00 pm
Close of Day 2
07:30 - 11:00 pm
Symposium Dinner

7:30 - 11:00 pm

Venue: Sergeants Mess Chowder Bay

6.45 pm – Transfers: Convention Centre Wharf outside Sofitel Sydney Hotel
Coach transfers back to Sofitel Sydney

Saturday 7 December 2019    Venue: Parkside Ballroom – Level 2
07:00 am
Registration Desk Open

7:00 - 7:00 am

Venue – Parkside Ballroom Level 2

VERVE Symposium: Room 1
08:00 - 09:30 am
Session 1.11: The Current State of Anti-Restenotic Therapy for the SFA

8:00 - 9:30 am

Chairs : G. Ansel, R. Varcoe
Panel : S. Bräunlich, Y. Gouëffic, V. Bourke, S. Kum

Supported by : Cook Medical

8:00 - 8:08 am

The BATTLE Trial: A RCT Comparing a Bare Metal Stent versus Paclitaxel Polymer Free Eluting Stent: 2-Year Outcomes
Yann Gouëffic

8:08 - 8:38 am

Live Case from Leipzig (case 19)

8:38 - 8:46 am

Latest Results from the REAL PTX Randomized Trial
Sven Bräunlich

8:46 - 8:54 am

Endovascular Intervention vs. Open Surgery for Lower Limb Ischaemia- Resources Optimization
Yew Toh Wong

8:54 - 9:02 am

Why we need to be scientific in our evaluation of pedal access utilization
Gary Ansel

9:02 - 9:10 am

Stretching and damage of the vessel wall due to SES deployment, a histological and mechanical evaluation
Matthew Pelletier

9:10 - 9:30 am

Discussion

09:30 - 11:00 am
Session 1.12 The BTK Challenges Just Keep Coming

9:30 - 11:00 am

Chairs : R. Varcoe, J. Van den Berg
Panel : R. Tripathi, M. Razavi, S. Bräunlich, A. Ling, R. Tripathi, Y. Gouëffic

9:30 - 9:38 am

Advanced Interventional Techniques to Conquer the Reclacitrant CTO: Has to Achieve 100% Technical Success
Sven Bräunlich

9:38 - 9:58 am

Live Case from Sydney POW (case 21)

9:58 - 10:06 am

Approaches after Failed CTO Crossing
Mahmood Razavi

10:06 - 10:14 am

The Use of Specialty Balloons in the BTK Segment
Jos Van den Berg

10:14 - 10:22 am

Balloon Based versus Stent Based Tibial Revascularisation: The Evidence for Each
Adrian Ling

10:22 - 10:30 am

French Guidelines for the Management of Ambulatory Endovascular Procedures for Lower Extremity Peripheral Artery Disease
Yann Gouëffic

10:30 - 10:38 am

Distal Bypasses Have An Important Role In The Treatment Of CLTI In The Endovascular Era: What Is That Role ?  
Ramesh Tripathi

10:38 - 11:00 am

Discussion

11:00 - 11:30 am
Morning Tea
11:30 - 01:00 pm
Session 1.13: The Final Word on AAA

11:30 - 11:38 am

Chairs : F. Criado, H. Verhagen
Panel : J. Iliopoulos, G. Benveniste, J. Van den Berg, E. Verhoeven, D. Schneider

11:30 - 11:38 am

Technical Lessons Learned in Over 1400 Fenestrated and Branched EVAR Cases
Eric Verhoeven

11:38 - 11:46 am

Combination Approach with fEVAR and chEVAR for Selected Anatomies
Eric Ducasse

11:46 - 11:52 am

Survival after EVAR in octogenarians is similar to a matched control group without an aortic aneurysm from the general population
Hence Verhagen

11:52 - 12:00 pm

Entirely Percutaneous Approaches to Complex EVAR
Darren Schneider

12:00 - 12:08 pm

Long-Term Follow-up from a Single-Surgeon, Data-Linkage Study in 180 Consecutive Patients with Abdominal Aortic Aneurysm Treated with the Endurant Stent Graft System
Glen Benveniste

12:08 - 12:16 pm

New Vascular Imaging Techniques: What Interventionalists Need to Know
Jos Van den Berg

12:16 - 12:24 pm

Most truly inoperable aneurysm patients should be left alone, without repair – regardless of aneurysm size
Frank Criado

12:24 - 12:32 pm

Outcomes of A Low Profile AAA Graft: InCraft
Kishore Sieunarine

12:32 - 12:40 pm

Evolution in Special Forces Trauma Training and Trauma Care/Surgery Since Afghanistan and Iraq
Jim Iliopoulos

12:40 - 12:48 pm

Management of Vascular Trauma in Military Settings
John Swinnen

12:48 - 1:00 pm

Discussion

01:00 - 02:00 pm
Lunch
02:00 - 05:00 pm
Session 1.14: Worst Ever Disasters & Challenging Cases

2:00 - 5:00 pm

Chairs : R. Varcoe, A. Lennox
Panel : H. Verhagen, R. Milner, E. Verhoeven, S. Thomas T. Nakama, S. Kum

2:00 - 2:07 pm

My Worst Ever Disaster…From Rotterdam
Hence Verhagen

2:07 - 2:14 pm

My Worst Ever Disaster…From Sydney
Ravi Huilgol

2:14 - 2:21 pm

My Worst Ever Disaster…From Tokyo
Tatsuya Nakama

2:21 - 2:28 pm

My Worst Ever Disaster…From Lugano
Jos Van den Berg

2:28 - 2:35 pm

My Worst Ever Disaster…From Nuremberg
Eric Verhoeven

2:35 - 2:42 pm

Percutaneous Transapical Approach For Placing Arch And Other Devices: How Is It Possible
Ross Milner

2:42 - 2:49 pm

A Rare Case of Bilateral Posterior Tibial Artery Aneurysm Presenting as Unilateral Acute Limb Ischemia
Andrew Hattam

2:49 - 2:56 pm

Aortic hygroma following endovascular repair of an abdominal aortic aneurysm
Thomas Cavaye

2:56 - 3:03 pm

Primary Retroperitoneal Pseudocysts: Beware of the Hoax Solid Enhancing Adrenal Mass
Matthew Farag

3:03 - 3:10 pm

Surprising renal recovery in an inflammatory abdominal aortic aneurysm
Paul Ghaly

3:10 - 3:17 pm

Percutaneous Endoluminal Anatomical Bypass for a Ligated External Iliac Artery
Tatsuya Nakama

3:17 - 3:24 pm

Aneurysm sac re-perfusion following thoracoabdominal endovascular aortic aneurysm repair to mitigate spinal cord ischaemia
Joseph Faraj

3:24 - 3:31 pm

SMA Syndrome causing gastric outlet obstruction
Kishan Liyanage

3:31 - 3:38 pm

Wrapping of an ascending aorta aneurysm and Hybrid technique for Acute TBAD in high risk patient
Son Nguyen

3:38 - 3:45 pm

Mycotic iliac artery pseudoaneurysm from disseminated Bacillus Calmette-Guerin mycobacteria
Kam Fai (Kelvin) Ho

3:45 - 3:52 pm

Hybrid revascularization in an old monk with TASC-D AIOD, how I do it?
Jaroen Cheewinmethasiri

3:52 - 3:59 pm

Lower extremity oedema as a sentinel symptom
Ian Barry

3:59 - 4:06 pm

Hybrid operative management of ruptured acute non-A/non-B aortic dissection
Enis Kocak

4:06 - 4:13 pm

A real pickle: Preserving erectile function in ruptured iliac aneurysms
Rebecca Reardon

4:13 - 4:20 pm

Getting flow A case of chronic and acute mesenteric ischaemia
Ina Liang

4:20 - 4:27 pm

A case of challenging BTK and BTA intervention with metatarsal artery puncture and BADFORM technique
Yuta Azumi

4:27 - 4:34 pm

Concurrent radiation induced aortoiliac occlusive disease and May Thurner syndrome; a novel endovascular approach and review of the literature.
Lucy Mauel

4:34 - 4:41 pm

A Novel Method of Concomitant In-situ Fenestration of Left Subclavian Artery in TEVAR-the J.D method
Ji Dong Liu

4:41 - 5:00 pm

Discussion

05:00 pm
Close of Symposium
VERVE Symposium: Room 2
08:00 - 09:30 am
Session 2.11: Current and Emerging Embolisation Techniques

8:00 - 9:30 am

Chair : J. Van den Berg
Panel : G. Goh, L. Baker, T. Kolbel

8:00 - 8:10 am

An Update on Treatment for Endoleaks
Jos Van den Berg

8:10 - 8:20 am

Anti-Reflux and Balloon Microcatheter Embolization – Game Changers?
Gerard Goh

8:20 - 8:50 am

Live Case from Sydney POW (case 20)

8:50 - 9:00 am

Transcaval Endoleak Embolisation
Tilo Kolbel

9:00 - 9:10 am

Direct Stick Puncture Technique to Manage Endoleaks
Luke Baker

9:10 - 9:20 am

Live Case from Sydney POW (case 20)

9:20 - 9:30 am

Discussion

09:30 - 11:00 am
Session 2.12: Venous Disease of the Lower Extremity

9:30 - 11:00 am

Chair : M. Malouf
Panel : N. Ibrahim, S. Roberts, I. Mohan, P. Premkumar

9:30 - 9:40 am

Highlights of Venous 2019 Meetings: My Take on Where the Future of Venous Therapies
Mark Malouf

9:40 - 9:50 am

Preliminary Experience of Cyanoacrylate Closure – Single Centre Data
Stefania Roberts

9:50 - 10:00 am

Vena-Plug: Cyanoacrylate Beyond Truncal Ablation
Nabeel Ibrahim

10:00 - 10:10 am

Unanswered Questions on Thermal Ablation of Truncal Venous Incompetence
Irwin Mohan

10:10 - 10:20 am

Unmasking Iliac veins abnormality by ascending venogram in venous ulcers
Prabhu Premkumar

10:20 - 10:30 am

Use of a sub-bandage pressure monitor to improve accuracy of pressure bandage applicatio
Gabrielle McMullin

10:30 - 10:40 am

Radiofrequency ablation of varicose veins: audit of outcomes from the public sector
Michael Smits

10:40 - 10:50 am

A Practical Guide to Sclerotherapy
Stefania Roberts

10:50 - 11:00 am

Discussion

11:00 - 11:30 am
Morning Tea
11:30 - 01:00 pm
Session 2.13: The Current Landscape in Carotid Revascularisation

11:30 - 1:00 pm

Chairs : P. Schneider, K. Rosenfeld
Panel : M. Schermerhorn, M. Neale, A. Bullen, R. Huilgol

11:30 - 11:38 am

Current Considerations for Patient Centred Revascularisation Strategies: CAS vs CEA vs BMT
Michael Neale

11:38 - 11:46 am

The Current Status of Carotid Stenting in 2019
Kenneth Rosenfield

11:46 - 11:54 am

New Devices and Techniques in Carotid Stenting
Andrew Bullen

11:54 - 12:02 pm

An Update on the Vascular Quality Initiative (VQI), Transcervical Carotid Revascularization Surveillance Project 
Marc Shermerhorn

12:02 - 12:10 pm

The Use of Micromesh Covered Stents in CAS
Ravi Huilgol

12:10 - 12:18 pm

Use of TCAR in recently symptomatic patients: Is it safe?
Peter Schneider

12:18 - 12:26 pm

PARADIGM-Extend prospective academic trial: Accumulating long-term evidence for MicroNet-covered stent safety and stroke prevention efficacy and Initial experience from Perth
Patrice Mwipitayi

12:26 - 12:34 pm

A tortuous internal carotid artery aneurysm
Reuben Chen

12:34 - 12:42 pm

Spontaneous Recanalisation of an Occluded Internal Carotid Artery
Rebecca Reardon

12:42 - 1:00 pm

Discussion

01:00 - 01:45 pm
Lunch